Yanming Jiang1,2, Fuqiang Yin3,4, Yujie Chen5, Liang Yue6, Li Li1,4. 1. Department of Gynecologic Oncology, Affiliated Tumor Hospital of Guangxi Medical University Nanning, Guangxi, China. 2. Department of Gynecology, The People's Hospital of Guangxi Zhuang Autonomous Region Nanning, Guangxi, China. 3. Life Sciences Institute, Guangxi Medical University Nanning, Guangxi, China. 4. Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education Nanning, Guangxi, China. 5. Department of Gynecology, Liuzhou People's Hospital Liuzhou, Guangxi, China. 6. Department of Pathology, Liuzhou People's Hospital Liuzhou, Guangxi, China.
Abstract
OBJECTIVE: To identify genes potentially associated with cervical intraepithelial neoplasia (CIN) progression through bioinformatic approaches and clinicopathological verification. METHODS: mRNA expression microarray data related to CIN progression were screened from the Gene Expression Omnibus (GEO) database and re-analyzed using bioinformatics approaches. Tissue microarray immunohistochemistry was conducted to assess the significant identified genes in CIN, cervical cancer, and normal tissues. RESULTS: Biological annotation and text mining showed that 14 differentially expressed genes were directly or indirectly related to CIN progression. The expression of 5 up-regulated differentially expressed genes, namely, CCND2, TGFBR2, PRKCB, SH3KBP1 and WNT2B, was examined by tissue microarray immunohistochemistry, with the known CIN progression genes P16 and Ki-67 as the internal reference. Expression of TGFBR2, SH3KBP1, and WNT2B were not detected in CIN and cervical carcinoma, whereas no significant difference in the expression rate of PRKCB was detected (P > 0.05). CCND2, P16, and Ki-67 expression showed a gradual increasing trend in normal, CIN, and cervical cancer. CONCLUSIONS: 14 differentially expressed genes were associated with CIN progression, as indicated by the microarray data analysis results. CCND2 may be a new marker for the prediction of CIN progression in addition to P16 and Ki-67. IJCEP
OBJECTIVE: To identify genes potentially associated with cervical intraepithelial neoplasia (CIN) progression through bioinformatic approaches and clinicopathological verification. METHODS: mRNA expression microarray data related to CIN progression were screened from the Gene Expression Omnibus (GEO) database and re-analyzed using bioinformatics approaches. Tissue microarray immunohistochemistry was conducted to assess the significant identified genes in CIN, cervical cancer, and normal tissues. RESULTS: Biological annotation and text mining showed that 14 differentially expressed genes were directly or indirectly related to CIN progression. The expression of 5 up-regulated differentially expressed genes, namely, CCND2, TGFBR2, PRKCB, SH3KBP1 and WNT2B, was examined by tissue microarray immunohistochemistry, with the known CIN progression genes P16 and Ki-67 as the internal reference. Expression of TGFBR2, SH3KBP1, and WNT2B were not detected in CIN and cervical carcinoma, whereas no significant difference in the expression rate of PRKCB was detected (P > 0.05). CCND2, P16, and Ki-67 expression showed a gradual increasing trend in normal, CIN, and cervical cancer. CONCLUSIONS: 14 differentially expressed genes were associated with CIN progression, as indicated by the microarray data analysis results. CCND2 may be a new marker for the prediction of CIN progression in addition to P16 and Ki-67. IJCEP
Authors: Elza M Fukazawa; Glauco Baiocchi; Fernando A Soares; Lillian Y Kumagai; Carlos C Faloppa; Levon Badiglian-Filho; Francisco R G Coelho; Wagner J Gonçalves; Ronaldo L R Costa; João C S Góes Journal: Int J Gynecol Pathol Date: 2014-05 Impact factor: 2.762
Authors: Nicole de Leeuw; Trijnie Dijkhuizen; Jayne Y Hehir-Kwa; Nigel P Carter; Lars Feuk; Helen V Firth; Robert M Kuhn; David H Ledbetter; Christa Lese Martin; Conny M A van Ravenswaaij-Arts; Steven W Scherer; Soheil Shams; Steven Van Vooren; Rolf Sijmons; Morris Swertz; Ros Hastings Journal: Hum Mutat Date: 2012-06 Impact factor: 4.878
Authors: Johan A den Boon; Dohun Pyeon; Sophia S Wang; Mark Horswill; Mark Schiffman; Mark Sherman; Rosemary E Zuna; Zhishi Wang; Stephen M Hewitt; Rachel Pearson; Meghan Schott; Lisa Chung; Qiuling He; Paul Lambert; Joan Walker; Michael A Newton; Nicolas Wentzensen; Paul Ahlquist Journal: Proc Natl Acad Sci U S A Date: 2015-06-08 Impact factor: 11.205
Authors: Dan Xie; Jonathan S T Sham; Wei-Fen Zeng; Han-Liang Lin; Li-Hong Che; Hui-Xi Wu; Jian-Ming Wen; Yan Fang; Liang Hu; Xin-Yuan Guan Journal: Int J Cancer Date: 2003-12-20 Impact factor: 7.396